Cargando…

Dose Consideration of Lenvatinib’s Anti-Cancer Effect on Hepatocellular Carcinoma and the Potential Benefit of Combined Colchicine Therapy

SIMPLE SUMMARY: The long-term benefits of lenvatinib on the treatment of advanced hepatocellular carcinoma (HCC) are still unsatisfactory. The search for a new drug to promote lenvatinib’s anti-cancer effect is an urgent issue. Whether the response of HCC to lenvatinib is dose-dependent also still n...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Zu-Yau, Yeh, Ming-Lun, Liang, Po-Cheng, Hsu, Po-Yao, Huang, Chung-Feng, Huang, Jee-Fu, Dai, Chia-Yen, Yu, Ming-Lung, Chuang, Wan-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605131/
https://www.ncbi.nlm.nih.gov/pubmed/37894463
http://dx.doi.org/10.3390/cancers15205097